1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. NEUROCRINE BIOSCIENCES, INC.

Neurocrine Biosciences, Inc. XNAS: NBIX

Mid-range Performer
Download real time

107.20 -0.04 (-0.04%)

32.14% Fall from 52W High

270.3K XNAS Volume

XNAS 30 Apr, 2025 12:57 PM (EDT)

Watchlist

Portfolio

Share
15S
8W
5O
0T
55.4

Day RSI

RSI is mid-range
80.2

Day MFI

MFI strongly Overbought
-0.2

Beta 1Year

Very Low volatility
108

50Day SMA

Price below SMA-50
125.8

200Day SMA

Price below SMA-200
Board Meeting
The next board meeting for Neurocrine Biosciences, Inc. is on 05 May 2025 for the purpose of Neurocrine Biosciences Inc First Quarter Earnings Results for 2025 See details

Neurocrine Biosciences, Inc. RSI, Moving Averages, Technical Analysis MACD, MFI, Stochastic and Candlesticks

Neurocrine Biosciences, Inc. technical analysis - SMA, EMA, Price Change analysis, 52 Week high low, Beta and volume delivery analysis